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Edited by Robert Russell and Giulio Superti-FurgaAbstract Pathway information is vital for successful quantita-
tive modeling of biological systems. The almost 170 online path-
way databases vary widely in coverage and representation of
biological processes, making their use extremely diﬃcult. Future
pathway information systems for querying, visualization and
analysis must support standard exchange formats to successfully
integrate data on a large scale. Such integrated systems will
greatly facilitate the constructive cycle of computational model
building and experimental veriﬁcation that lies at the heart of
systems biology.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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To understand biological processes, we must integrate new
observations with existing knowledge to create testable models
that can be iteratively reﬁned. This will only be successful if the
vast amounts of data gathered by large-scale proﬁling of bio-
logical features, such as mRNA transcripts and proteins, can
be eﬃciently integrated with data from the literature and dat-
abases for visualization and analysis.
One major source for computable data about biological pro-
cesses are databases that capture information on the functional
interactions of molecular species [1]. These ‘‘pathway’’ dat-
abases facilitate a variety of analysis and simulation techniques
that can enrich our understanding of cellular systems.
While recent dramatic growth in the number of pathway
databases is a great boon to biologists, it also presents several
important challenges. Almost 170 ‘‘pathway’’ databases exist,
which diﬀer widely in form and content. This multiplicity of
information sources can be daunting to researchers who simply
wish to ﬁnd information about genes or pathways of interest.
The lack of uniform data models and data access methods
makes pathway data integration extremely diﬃcult, both
mechanistically and semantically.
To address these issues, it is useful to review the current
landscape of pathway data and techniques for data integra-
tion, and then to extrapolate the shape of desirable pathwayE-mail address: pathways_febs@cbio.mskcc.org.
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doi:10.1016/j.febslet.2005.02.005information systems which ﬂexibly and eﬃciently facilitate
the analysis and modeling of biological systems.2. Surveying the pathway data landscape
One abstraction that biologists have found extremely useful
in their eﬀorts to describe and understand the inner workings
of cellular biology is the notion of a biomolecular network, of-
ten called a pathway. A pathway is a set of interactions, or
functional relationships, between the physical and/or genetic
[2] components of the cell which operate in concert to carry
out a biological process. Despite tremendous variety in the cel-
lular processes described as pathways, several pathway repre-
sentation patterns are prevalent in current practice. In the
Pathway Resource List, a catalog of almost 170 pathway dat-
abases (see http://cbio.mskcc.org/prl), we use these patterns to
group pathway databases into four major, slightly overlapping
categories: metabolic, signaling, protein interaction, and gene
regulation. A description of the major features of these
categories provides an overview of the current pathway data
landscape.
Metabolic pathway databases generally contain detailed data
models that represent a pathway as a series of biochemical
reactions, focusing mainly on the chemical modiﬁcations made
to the small molecule substrates of enzymes (Fig. 1A). Many
metabolic pathways have been mapped to the molecular level
of detail since the 1950s or earlier and metabolic pathway dat-
abases are the earliest and perhaps the best-known. Metabolic
databases generally do not represent higher order cellular pro-
cesses, such as gene regulation.
Metabolic databases predominantly contain prokaryotic
pathways, about which rich datasets have been collected.
A few metabolic pathway databases, for example KEGG
[3], the BioCyc database family [4] and others [5], map path-
ways from well-studied organisms onto other organisms via
functional annotations, such as Enzyme Commission num-
bers [6], and orthology relationships, but these approaches
are imperfect and the resulting pathways often contain a
number of gaps, i.e., missing steps in a chain of biochemical
reactions. Gap-ﬁlling algorithms attempt to address this
problem [7].
Signaling pathways propagate information from one part or
sub-process of the cell to another, often via a series of protein
covalent modiﬁcations, such as protein phosphorylation. Dys-
regulation of biological processes by aberrant signaling path-
ways causes many common diseases, such as cancer andblished by Elsevier B.V. All rights reserved.
Fig. 1. Common alternative representations of pathway data. (A) Section of the glycolysis 1 pathway diagram from EcoCyc [50], drawn in high detail
mode, showing a single biochemical reaction. Blue arrows depict biochemical conversion of substrates to products. The conversion arrows are labeled
with the catalyzing enzyme using gold text. (B) Section of a molecular interaction map from the eMIM resource [51] showing regulation of hypoxia-
responsive genes. Diagram shows phosphorylation events (blue arrows originating in blue letter Ps; phosphorylation sites, if known, are abbreviated
in superscript, e.g., S209 = serine 209), inhibitory relationships (red ﬂat-headed arrows), enzymatic stimulation of events (green lines ending in open
circles), binding interactions (black double-headed arrows), and non-speciﬁc stimulation of events (green arrows). Proteins are shown in black ovals,
nodes (ﬁlled circles) placed on lines represent the products of processes; e.g., the node on the binding interaction arrow between eIF4E and eIF4G
represents the eIF4E:eIF4G complex. (C) Section of the WNT pathway diagram from HPRD [21]. Proteins identiﬁed as important components of
the pathway are shown as red boxes, other proteins are depicted as small yellow circles. Protein–protein interactions are drawn as edges between
proteins. (D) Section of the endomesoderm gene network in the BioTapestry network viewer (see http://www.biotapestry.org). Genes are shown as
short, thick horizontal lines. Gene products are represented as short vertical arrows originating at genes and ending in right angles. Activating and
inhibitory relationships are shown as normal and ﬂat-headed arrows, respectively, drawn from gene products to regulated genes.
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pathway databases, signaling pathway databases are being ac-
tively constructed by a number of groups.
As many signaling pathways are present only in multi-cellu-
lar organisms, signaling databases tend to focus on eukaryotes.
These organisms are much more complex and less well-studied
than some bacteria and their signaling pathways appear to be
more diverse than metabolic pathways. Accordingly, signaling
pathway databases tend to use higher level abstractions com-
pared to metabolic databases (Fig. 1B). For example, CSNDB
[10], TRANSPATH [11] and others [12,13], often forego de-
tailed description of the biochemical reactions involved in sig-
naling and instead use generic concepts of activation and
inhibition.Protein interaction databases contain by far the largest num-
ber of interactions of any type of pathway database. Large
amounts of protein interactions (protein–protein, protein–
DNA, etc.) are generated by various large-scale experimental
methods, unlike metabolic and signaling pathway data, which
are generated primarily by traditional small-scale experimental
techniques [14]. A well-known problem with most high
throughput methods of detecting molecular interactions is
the high rate of false positive results they generate [15]. Protein
interactions detected by these methods should therefore be
treated with less conﬁdence until they have been veriﬁed by re-
peated observations or orthogonal experiments [16], and stor-
ing experimental evidence for each interaction is important for
most protein interaction databases.
Fig. 2. The iterative biological system modeling method. Biological
knowledge from a variety of sources, including molecular interaction
surveys and molecular and genetic proﬁles, pathway databases and
literature populate information systems that support data storage,
querying, visualization and analysis. These information systems
support the construction of computational models of cellular pro-
cesses, which are used to make testable predictions of cellular behavior.
Experimental results must be compared to these predictions and used
for model reﬁnement.
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tion databases tend to be the least detailed (Fig. 1C), although
they often have broad organism coverage [17,18]. GRID [19],
for example, stores only the that fact that an interaction was
observed between two proteins in at least one experiment.
Some databases add additional detail, such as binding sites
or, if known, the functional consequences of an interaction
on the participants [20,21].
Gene regulation databases currently tend to focus on the
relationships between transcription factors and the genes they
regulate (Fig. 1D). These databases also have broad organism
coverage and share features with both signaling and protein
interaction databases, as they collect protein–DNA interac-
tions [22] and regulatory (activation and inhibition) events
[23]. Some genetic regulatory databases incorporate protein–
DNA binding data from high-throughput assays, such as chro-
matin immunoprecipitation followed by cDNA microarray
analysis (ChIP2) [24]. This transcription factor-DNA binding
information only indicates that the prerequisite of classical
gene regulation, transcription factor binding upstream of a
regulated gene, can occur – it does not provide information
on the functional consequences, if any, of a DNA–protein
binding interaction. Other aspects of gene regulation, such as
control of alternative splicing, post-transcriptional regulation
of protein expression and regulation of the degradation of gene
products, are currently rarely covered in gene regulation
databases.
Though the attributes metabolic, signaling, protein inter-
action, and gene regulation serve as useful distinctions for
discussing pathway data, these categories arise from experi-
mental capabilities, research trends and common abstractions
of biological relationships, and do not correspond closely to
physical or chemical features of cellular biology. Furthermore,
this classiﬁcation scheme is not logically disjoint, universally
accepted, nor all inclusive. Some databases span multiple cat-
egories, such as Reactome [25], which we might classify as both
a metabolic and a signaling database. Others do not ﬁt into
these categories, such as those that store genetic interactions
[26], and databases that store literature co-cited gene name
links [27] or more detailed literature extracted links [28]. While
these databases may not be universally considered pathway
databases, they contain valuable functional links between
genes, many of which are not available in other pathway dat-
abases. While integration of these diverse data sets is challeng-
ing, an inclusive deﬁnition of pathway data is necessary to
cover existing knowledge and to generate ﬂexible and accurate
input for model building in systems biology.3. Using pathway data to answer biological questions
The principal motivation for building pathway databases
and information systems (Fig. 2) is to facilitate qualitative
and quantitative modeling of biological systems, outside of
the direct capacity of the human brain, using software on pow-
erful computers. A wide range of techniques have been devel-
oped that use pathway data of varying detail to answer speciﬁc
biological questions.
Questions such as What are the fundamental design pat-
terns in the system?, What are the key relationships between
system components? and What are the physiological eﬀectsof system perturbation? can be answered using quantitative
and qualitative modeling. Quantitative modeling, such as rep-
resenting a dynamic chemical process using a system of diﬀer-
ential rate equations, requires highly detailed pathway
information, such as kinetic constants, initial concentrations
and clear connectivity of reactions. Some of this information
is available in metabolic pathway databases and the literature
[29].
Qualitative models are easier to build because they require
much less detailed knowledge of the system. Using only topog-
raphy information [30] and/or qualitative information about
reaction rates (e.g., fast or slow) [31], qualitative models can
discover system properties not apparent in static pathway
data.
Evolution-focused questions, such as Which biological pro-
cesses are homologous?, can be answered using techniques
that identify common functional motifs and design principles,
e.g., through species comparison. For example, PathBLAST
[32] can align protein–protein interaction networks and pro-
cess algebra techniques [33] can be used to formally deﬁne pro-
cess homology (bi-similarity).
Though many pathway databases only store interactions
between genes, proteins and other cellular components, there
is clear evidence for higher-order organization in these net-
works. Can we determine how networks are organized and
create abstractions that serve as more eﬀective descriptions
of network features? A number of groups have tried to an-
swer this question using only the molecular interaction net-
work topology [34]. Molecular interaction networks have
been found to cluster into regions that represent complexes
[35] or processes [36]. Statistically over-represented motifs
have also been found [37] and some of these have been thor-
oughly analyzed [38].
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are still vitally important, since the majority of genes in most
genomes have no known function. Examining genes in the net-
work context can help answer this question. For example, a
protein of unknown function connected to a set of proteins in-
volved in the same biological process is likely to function in
that process as well [39,40].
Less-detailed pathway data, such as proteomics-based pro-
tein–protein interactions, can be used to answer questions like
What network patterns allow prediction of new interactions?
For example, statistically signiﬁcant domain–domain correla-
tions in a protein interaction network have been used to
hypothesize that certain domains mediate binding interactions
and to predict new interactions [41,42]. Machine learning tech-
niques can also be used to predict protein–protein [43] or ge-
netic interactions [44].
Finally, questions such as What biologically relevant pat-
terns in molecular and genetic proﬁling data relate to disease?
are vitally important for clinical health research and require a
large amount of pathway data to answer eﬀectively. For exam-
ple, transcriptionally active neighborhoods or regions in an
integrated pathway network that correlate with disease state
may indicate active pathway components that play a role in
disease progression and provide leads for further study [45,46].4. Pathway data integration for systems biology
The power of many pathway analysis techniques is propor-
tional to the amount of input pathway data. For example,
the activity centers algorithm [46] relies on connections be-
tween genes in order to detect regions of the interaction net-
work that are up- or downregulated; missing connections
could cause an important active region to go unnoticed by
the algorithm. Thus, it is vital that as much pathway data as
possible is available for the organism being studied.
The diversity among pathway databases makes this chal-
lenging. Diﬀerences in data models, data access methods, ﬁle
formats and subtle semantic diﬀerences in shared terms create
numerous diﬃculties for those attempting to gather and ana-
lyze data from multiple sources. Creation of a new data model
is sometimes important for a particular groups research, the
continued proliferation of new pathway databases, each with
their own format, aggravates the data integration problem.
One way to overcome this challenge is to develop a widely
supported pathway data standard. Data standards reduce the
total number of translation operations needed to exchange
data between multiple sources (from n2  n to 2n, where n is
the total number of data suppliers and consumers). They also
distribute the reduced translation burden more evenly between
data consumers and data providers and facilitate collaboration
and accessibility of pathway data to newcomers, thus promot-
ing growth. Because of this, data standards are one of the
few scalable data integration strategies (see [47] for a recent
review).
Pathway data standards exist, but none cover all aspects of
pathway data (Fig. 3). CellML [48] and SBML [49] both are
designed to represent quantitative pathway simulation models
that can be exchanged between simulation software packages.
Since they do not contain data types for many concepts com-
monly represented in pathway databases, such as transport orRNA, these formats are not well suited for data exchange be-
tween databases.
The Proteomics Standards Initiatives Molecular Interaction
(PSI-MI) format [48], has been developed recently to exchange
molecular interaction data between major protein–protein
interaction databases. PSI-MI is developed in a practical lev-
eled approach, following the lead of SBML, in which each level
adds additional data representation capabilities. PSI-MI Level
1 is designed to represent proteomics protein–protein interac-
tion data, including experimental method description. PSI-
MI Level 2 expands this scope to include interactions involving
small molecules, DNA and RNA. Though it is relatively new,
a number of molecular interaction databases already support
data export in the PSI-MI format (e.g., BIND [20], DIP [16],
HPRD [21], IntAct [17], and MINT [18]).
To capture more of the pathway data that currently resides
in databases, BioPAX (http://www.biopax.org) is being devel-
oped by various pathway database groups, also using a leveled
approach. Because many less-detailed data types that exist in
the pathway data space are diﬃcult to represent in a highly de-
tailed format, the BioPAX ontology allows representation of
multiple levels of data resolution using an abstraction hierar-
chy. This feature is essential for capturing data from the dispa-
rate sources of pathway data in a convenient manner. BioPAX
Level 1, released in mid-2004, is designed to represent meta-
bolic pathway data and Level 2, near release, adds support
for PSI-MI molecular interaction data. Future levels of the
format will expand scope to include signaling pathways and
genetic interactions.5. Future directions
The ultimate aim of projects like PSI-MI and BioPAX is to
enable eﬀortless collection of pathway data so that it may be
eﬃciently applied to answer biological questions. Ideally, biol-
ogists should never need to perform time-consuming data col-
lection tasks in order to perform a particular analysis. Instead,
they should be able to locate, retrieve and apply data of inter-
est without worrying about data models, exchange formats, or
integration methods.
To achieve this goal, data standards must become broadly
adopted by pathway databases. This would enable a variety
of large-scale data integration approaches, such as a central-
ized or distributed pathway data warehouse or a query engine
able to retrieve data from multiple standards-compliant pri-
mary databases. Importantly, pathway data analysis tools
must be built to interface with these integration systems to
make pathway data retrieval painless.
Widely accepted data standards and integration infrastruc-
ture can also streamline one limiting factor for pathway data-
base growth, namely pathway database curation through
manual scientiﬁc literature mining. A uniﬁed, but distributed
curation eﬀort built on accepted curation and data validation
tools, involving many biologists, may ﬁnally provide a cost-
eﬀective data entry solution that scales with exponential data
growth. Journals could support this eﬀort by making public
pathway data deposition a precondition for publication, as
many have done with sequence and structure data.
With public data sharing infrastructure, we can build soft-
ware platforms that allow high-level and eﬀective pathway
Fig. 3. Data coverage of pathway data formats. Pathway data space is represented two-dimensionally with physical entity classes vertically and
interaction types horizontally. Approximate coverage of this space by each pathway data format is represented with colored boxes; database
exchange formats are shown in blue, simulation model exchange formats are shown in green. Versions (e.g., level 1, 2, etc.) of a format that have
diﬀerent scope are drawn in separate boxes; formats with similar scope are shown in the same box. The dashed border indicates planned versions not
yet available.
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abstractions. When combined with the trend towards cheap,
high-throughput cellular proﬁling technology, we can imagine
a swift convergence on biological process understanding
through iterative systems biology modeling methods.References
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